Evidence map›Paper›PMID 34850958›Full record

ArticleMolecular medicine reports2022

Corilagin induces apoptosis and inhibits autophagy of HL‑60 cells by regulating miR‑451/HMGB1 axis.

Shu Jia, Dongye He, Xiao Liang, Panpan Cheng, Jilan Liu, Mingtai Chen, Cuiling Wang, Hao Zhang, Chunyang Meng

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shu Jia *Medical Research Center, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Dongye He *Medical Research Center, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Xiao LiangDepartment of Spine Surgery, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Panpan ChengDepartment of Hematology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Jilan LiuMedical Research Center, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Mingtai ChenMedical Research Center, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Cuiling WangDepartment of Hematology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Hao ZhangDepartment of Hematology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Chunyang MengDepartment of Spine Surgery, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Affiliated Hospital of Jining Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corilagin is the primary active component of the

Indexed as

ApoptosisAutophagyCell ProliferationGene Expression Regulation, NeoplasticGlucosidesHL-60 CellsHMGB1 ProteinHumansHydrolyzable TanninsLeukemia, Myeloid, AcuteMicroRNAscorilaginGlucosidesHMGB1 ProteinHMGB1 protein, humanHydrolyzable TanninsMicroRNAsMIRN451 microRNA, humanacute myeloid leukemiaapoptosisautophagycorilaginhigh mobility group protein B1miR‑451

Identifiers

PMID34850958
PMCPMC8669704
OpenAlexW3215947978

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.